Tofacitinib suppresses disease activity and febrile attacks in a patient with coexisting rheumatoid arthritis and familial Mediterranean fever
Familial Mediterranean fever (FMF) is the most common hereditary auto-inflammatory (periodic fever) syndrome, and usually successfully treated with colchicine. However, nearly 5-10% of FMF cases are resistant or intolerant to colchicine and treatment options are highly restricted in these cases. Bio...
Main Authors: | Kevser Gök, Gizem Cengiz, Kemal Erol, Salih Ozgocmen |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Portuguesa de Reumatologia
2017-01-01
|
Series: | Acta Reumatológica Portuguesa |
Subjects: | |
Online Access: | http://www.actareumatologica.com/files/article/1160_tofacitinib_suppresses_disease_activity_and_febrile_attacks_in_a_patient_with_coexisting_rheumatoid_arthritis_and_familial_mediterranean_fever_file.pdf |
Similar Items
-
Protracted Febrile Myalgia in a Child as the Presenting Sign of Familial Mediterranean Fever: Case Report and Review of the Literature
by: İbrahim Gökçe, et al.
Published: (2011-06-01) -
Coexisting Diseases in Patients with Familial Mediterranean Fever
by: Salehzadeh F, et al.
Published: (2020-05-01) -
Letter to the Editor: Coexistence of Autoimmune Lymphoproliferative Syndrome and Familial Mediterranean Fever
by: Sultan Aydin Koker, et al.
Published: (2020-06-01) -
A rare cause of fever in an adult: a case of familial Mediterranean fever
by: Erdem I, et al.
Published: (2018-03-01) -
Mediterranean Spotted Fever: A Review of 14 Cases
by: Ali MERT, et al.
Published: (2003-06-01)